Genelux (GNLX) Competitors

Precigen (NASDAQ:PGEN) and Genelux (NASDAQ:GNLX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.

Which has more risk and volatility, PGEN or GNLX?

Precigen has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, Genelux has a beta of -1.41, suggesting that its stock price is 241% less volatile than the S&P 500.

Does the MarketBeat Community believe in PGEN or GNLX?

Precigen received 421 more outperform votes than Genelux when rated by MarketBeat users. However, 100.00% of users gave Genelux an outperform vote while only 67.44% of users gave Precigen an outperform vote.

Company	Underperform	Outperform
Precigen	Outperform Votes 437 67.44%	Underperform Votes 211 32.56%
Genelux	Outperform Votes 16 100.00%	Underperform Votes No Votes

Does the media favor PGEN or GNLX?

In the previous week, Genelux had 29 more articles in the media than Precigen. MarketBeat recorded 35 mentions for Genelux and 6 mentions for Precigen. Genelux's average media sentiment score of 0.71 beat Precigen's score of 0.35 indicating that Genelux is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precigen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Genelux	5 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of PGEN or GNLX?

33.5% of Precigen shares are held by institutional investors. Comparatively, 37.3% of Genelux shares are held by institutional investors. 44.9% of Precigen shares are held by company insiders. Comparatively, 9.3% of Genelux shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Do analysts recommend PGEN or GNLX?

Precigen currently has a consensus price target of $7.00, suggesting a potential upside of 384.43%. Genelux has a consensus price target of $18.25, suggesting a potential upside of 535.89%. Given Genelux's stronger consensus rating and higher probable upside, analysts plainly believe Genelux is more favorable than Precigen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precigen	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Genelux	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Which has better earnings and valuation, PGEN or GNLX?

Genelux has lower revenue, but higher earnings than Precigen. Genelux is trading at a lower price-to-earnings ratio than Precigen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precigen	$3.93M	108.25	-$95.90M	-$0.48	-3.01
Genelux	$8K	12,390.51	-$28.30M	-$0.95	-3.02

Is PGEN or GNLX more profitable?

Genelux has a net margin of 0.00% compared to Precigen's net margin of -3,521.68%. Genelux's return on equity of -105.05% beat Precigen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precigen	-3,521.68%	-123.06%	-87.33%
Genelux	N/A	-105.05%	-80.16%

Summary

Genelux beats Precigen on 12 of the 18 factors compared between the two stocks.